UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
La revue de medecine interne, ISSN 0248-8663, 12/2017, Volume 38, pp. A204 - A204
Journal Article
Acta biomaterialia, ISSN 1742-7061, 01/2017, Volume 48, pp. 247 - 257
Catechols | Rectal drug delivery | Chitosan | Mucoadhesion | Ulcerative colitis | Engineering | Materials Science | Technology | Engineering, Biomedical | Materials Science, Biomaterials | Science & Technology | Sulfasalazine - therapeutic use | Tumor Necrosis Factor-alpha - metabolism | Colon - pathology | Colon - drug effects | Body Weight - drug effects | Catechols - chemistry | Sulfasalazine - pharmacology | Colitis, Ulcerative - pathology | Mucins - chemistry | Sulfasalazine - metabolism | Colitis, Ulcerative - blood | Adhesives - chemistry | Drug Delivery Systems | Dose-Response Relationship, Drug | Animals | Chitosan - chemistry | Rectum - drug effects | Sulfasalazine - blood | Mice | Occult Blood | Colitis, Ulcerative - drug therapy | Hydrogels - chemistry | Drugs | Drug delivery systems | Drug therapy | Vehicles | Hypertension | Evaluation | Colon cancer | Aminosalicylic acids | Microbiota (Symbiotic organisms) | Analysis | Gastrointestinal system | Inflammatory bowel diseases | Hydrogels | Mucosa | Drug delivery | Sulfapyridine | Retention time | Tissues | Retention | Small intestine | Genipin | Degradation | Absorption | Rodents | Sulfasalazine | Colon | Intestinal microflora | Formulations | Effectiveness | Degradation products | Vessels | Oral administration | Byproducts | Crosslinking | Gastrointestinal tract | Catechol | Inflammatory bowel disease | Side effects | Flora | Rectum | Index Medicus
Journal Article
International journal of hydrogen energy, ISSN 0360-3199, 07/2020, Volume 45, Issue 38, p. 19144
Journal Article
Environmental science and pollution research international, ISSN 0944-1344, 12/2020, Volume 27, Issue 35, p. 44292
Journal Article
The New England journal of medicine, ISSN 0028-4793, 07/2013, Volume 369, Issue 4, pp. 307 - 318
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Inflammatory joint diseases | Biological and medical sciences | General aspects | Medical sciences | Diseases of the osteoarticular system | Hydroxychloroquine - therapeutic use | Severity of Illness Index | Sulfasalazine - therapeutic use | Double-Blind Method | Humans | Middle Aged | Immunoglobulin G - therapeutic use | Male | Hydroxychloroquine - adverse effects | Methotrexate - therapeutic use | Immunoglobulin G - adverse effects | Receptors, Tumor Necrosis Factor - therapeutic use | Methotrexate - adverse effects | Etanercept | Arthritis, Rheumatoid - drug therapy | Treatment Failure | Antirheumatic Agents - adverse effects | Female | Aged | Drug Therapy, Combination | Sulfasalazine - adverse effects | Antirheumatic Agents - therapeutic use | Care and treatment | Antirheumatic agents | Research | Comparative analysis | Rheumatoid arthritis | Hydroxychloroquine | Pain | Clinical trials | TNF inhibitors | Sulfasalazine | Methotrexate | Drug therapy | Patients | Quality of life | Index Medicus | Abridged Index Medicus
Journal Article
Angewandte Chemie (International ed.), ISSN 1433-7851, 12/2012, Volume 51, Issue 50, pp. 12486 - 12489
colon targeting | sulfasalazine | nanoparticles | drug delivery | azo‐reductase | azo-reductase | Physical Sciences | Chemistry | Chemistry, Multidisciplinary | Science & Technology | Sulfapyridine - metabolism | Oxidoreductases - metabolism | Nanospheres - chemistry | Silicon Dioxide - chemistry | Sulfapyridine - chemistry | Prodrugs - chemistry | Sulfasalazine - metabolism | Drug Carriers - chemistry | Prodrugs - metabolism | Mesalamine - chemistry | Sulfasalazine - chemistry | Porosity | Mesalamine - metabolism | Hydrogen-Ion Concentration | Drugs | Sulfasalazine | Drug delivery systems | Silica | Vehicles | Index Medicus
Journal Article
Nature medicine, ISSN 1078-8956, 10/2011, Volume 17, Issue 10, pp. 1269 - 1274
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Sulfasalazine - therapeutic use | Humans | Electrophysiology | Cell Transplantation | Sulfasalazine - pharmacology | Electroencephalography | Brain Neoplasms - complications | Brain Neoplasms - drug therapy | Mice, SCID | Epilepsy - etiology | Brain Neoplasms - metabolism | Glioma - metabolism | Amino Acid Transport System y+ - metabolism | Animals | Analysis of Variance | Amino Acid Transport System y+ - antagonists & inhibitors | Glutamic Acid - metabolism | Mice | Epilepsy - pathology | Glioma - drug therapy | Complications and side effects | Prognosis | Epilepsy | Brain tumors | Physiological aspects | Development and progression | Genetic aspects | Research | Glutamate | Risk factors | Brain | Convulsions & seizures | Biomedical research | Tumors | Index Medicus
Journal Article
Journal of colloid and interface science, ISSN 0021-9797, 11/2015, Volume 458, pp. 217 - 228
Nanoparticles | Eudragit copolymer | Inflammatory | Sulfasalazine | Oral drug delivery | Layered double hydroxides | Physical Sciences | Chemistry | Chemistry, Physical | Science & Technology | Sulfasalazine - therapeutic use | Hydroxides - chemistry | Nanoparticles - chemistry | Humans | Biological Availability | Sulfasalazine - pharmacology | Edema - drug therapy | Polymethacrylic Acids - chemistry | Spectroscopy, Fourier Transform Infrared | Drug Carriers - chemistry | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | HT29 Cells | Animals | Sulfasalazine - pharmacokinetics | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Inflammation - drug therapy | Cell Line, Tumor | Mice | Laminated metals | Hydroxides | Index Medicus
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 04/2016, Volume 2016, Issue 6, pp. CD000543 - CD000543
Colitis, Ulcerative | Mesalamine | Administration, Oral | Gastroenterology & hepatology | Anti‐Inflammatory Agents, Non‐Steroidal | Induction Chemotherapy | Ulcerative colitis: induction of remission | Randomized Controlled Trials as Topic | Inflammatory bowel disease | 5‐ASA therapy, topical and oral | Treatment Failure | Child health | Gastroenterology | Sulfasalazine | Medicine General & Introductory Medical Sciences | ULCERATIVE COLITIS ‐ INDUCTION OF REMISSION | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Sulfasalazine - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Mesalamine - adverse effects | Humans | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Induction Chemotherapy - methods | Colitis, Ulcerative - drug therapy | Sulfasalazine - adverse effects | Mesalamine - administration & dosage | Index Medicus
Journal Article